Recent Advances in Nanocarriers for Drug Delivery
A special issue of Pharmaceuticals (ISSN 1424-8247). This special issue belongs to the section "Pharmaceutical Technology".
Deadline for manuscript submissions: 15 September 2025 | Viewed by 1057
Special Issue Editor
Interests: nanocarriers; drug delivery; targeted therapy; controlled release; biocompatibility; liposomal delivery; polymeric nanoparticles; gene therapy; smart drug systems; biomedical applications
Special Issues, Collections and Topics in MDPI journals
Special Issue Information
Dear Colleagues,
We are pleased to announce this Special Issue, “Recent Advance in Nanocarriers for Drug Delivery”, designed to highlight the potential of recent advancements, innovative research, and emerging directions for nanocarriers in drug delivery.
Nanocarriers have revolutionized the field of drug delivery by offering enhanced bioavailability, targeted delivery, controlled release, and improved therapeutic efficacy. Their diverse structures, including liposomes, polymeric nanoparticles, dendrimers, micelles, and inorganic nanoparticles, enable the precise and efficient transport of drugs to specific sites, reducing side effects and optimizing treatment outcomes. This Special Issue aims to provide a comprehensive platform for the exploration of novel nanocarrier-based drug delivery systems and to foster interdisciplinary research in this rapidly evolving field.
We welcome original research articles, reviews, and short communications covering, but not limited to, the following topics:
- Design, synthesis, and characterization of novel nanocarriers.
- Nanocarriers for targeted and personalized medicine.
- Stimuli-responsive and smart drug delivery systems.
- Advances in polymeric, lipid-based, and inorganic nanocarriers.
- Nanocarriers for gene therapy and nucleic acid delivery.
- Applications in cancer therapy, infectious diseases, and regenerative medicine.
- Overcoming biological barriers for efficient drug delivery.
- Toxicity, biocompatibility, and regulatory aspects of nanocarriers.
Publishing in this Special Issue offers the opportunity to be part of a highly relevant and impactful collection of research focused on cutting-edge developments in nanocarrier-based drug delivery. Articles in this Special ssue will benefit from high visibility and a targeted readership of peers interested in nanomedicine, pharmaceutical sciences, biomedical engineering, and clinical applications.
Authors are encouraged to clearly state the novelty, significance, and potential biomedical applications of their work within their manuscripts.
Prof. Dr. Liliana Mititelu-Tartau
Guest Editor
Manuscript Submission Information
Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Pharmaceuticals is an international peer-reviewed open access monthly journal published by MDPI.
Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2900 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.
Keywords
- nanocarriers
- drug delivery
- targeted therapy
- controlled release
- biocompatibility
- liposomal delivery
- polymeric nanoparticles
- gene therapy
- smart drug systems
- biomedical applications
Benefits of Publishing in a Special Issue
- Ease of navigation: Grouping papers by topic helps scholars navigate broad scope journals more efficiently.
- Greater discoverability: Special Issues support the reach and impact of scientific research. Articles in Special Issues are more discoverable and cited more frequently.
- Expansion of research network: Special Issues facilitate connections among authors, fostering scientific collaborations.
- External promotion: Articles in Special Issues are often promoted through the journal's social media, increasing their visibility.
- Reprint: MDPI Books provides the opportunity to republish successful Special Issues in book format, both online and in print.
Further information on MDPI's Special Issue policies can be found here.